株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

新興国の体外診断 (IVD) 市場 - 2022年までの予測:計器、試薬、ソフトウェア

IVD Market in BRIC by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China) - Forecast to 2022

発行 MarketsandMarkets 商品コード 500401
出版日 ページ情報 英文 281 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.53円で換算しております。
Back to Top
新興国の体外診断 (IVD) 市場 - 2022年までの予測:計器、試薬、ソフトウェア IVD Market in BRIC by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China) - Forecast to 2022
出版日: 2017年05月08日 ページ情報: 英文 281 Pages
概要

新興国の体外診断 (IVD) 市場は、2017年の106億米ドルから、2022年までに157億米ドルまで拡大すると見られています。市場は、2017年〜2022年のCAGR (複合年間成長率) で、8.2%の成長が予測されています。

当レポートでは、新興国の体外診断 (IVD) 市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 新興国の体外診断 (IVD) 市場:市場概要
  • 新興国の体外診断 (IVD) 市場:製品・サービス別

第5章 新興国の体外診断 (IVD) 市場:産業考察

  • イントロダクション
  • 産業動向
  • 規制概要

第6章 新興国の体外診断 (IVD) 市場:概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第7章 新興国の体外診断 (IVD) 市場:製品・サービス別

  • イントロダクション
  • 試薬・キット
  • 計器
  • データ管理システム/ソフトウェア
  • サービス

第8章 新興国の体外診断 (IVD) 市場:技術別

  • イントロダクション
  • イムノアッセイ/免疫化学
  • 臨床化学
  • 分子診断
  • 臨床微生物学
  • 血液学
  • 凝固・止血
  • その他

第9章 新興国の体外診断 (IVD) 市場:適応別

  • イントロダクション
  • 糖尿病
  • 感染症
  • 腫瘍学/がん
  • 心臓病学
  • 腎臓病学
  • 自己免疫疾患
  • 薬物検査/薬理ゲノム学
  • HIV/エイズ
  • その他

第10章 新興国の体外診断 (IVD) 市場:エンドユーザー別

  • イントロダクション
  • 病院の研究所
  • 臨床/関連研究所
  • ポイントオブケア検査
  • 患者の自己診断
  • 学術機関
  • その他

第11章 新興国の体外診断 (IVD) 市場:国別

  • イントロダクション
  • 中国
  • インド
  • ロシア
  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
  • チリ
  • 韓国
  • トルコ
  • サウジアラビア
  • タイ
  • マレーシア
  • インドネシア

第12章 競合情勢

  • イントロダクション
  • 先駆企業
  • 革新企業
  • 新興企業
  • 動的企業
  • 競合ベンチマーキング

第13章 企業プロファイル

  • ROCHE DIAGNOSTICS
  • ABBOTT LABORATORIES, INC.
  • BECTON, DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • DANAHER CORPORATION
  • JOHNSON & JOHNSON SERVICES, INC.
  • ORTHO-CLINICAL DIAGNOSTICS, INC.
  • QIAGEN N.V.
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC INC.
  • SIEMENS AG
  • DIASORIN S.P.A.

第14章 付録

目次
Product Code: MD 1223

The IVD market in BRIC is expected to reach USD 15.71 billion by 2022 from USD 10.60 billion in 2017, at a CAGR of 8.2%.

The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers, and improving healthcare system in emerging countries. However, market growth is restrained by the lack of reimbursement and the slow growth of the economy in some emerging countries.

In this report, the market is segmented by product & service, technology, application, end user, and country. Based on technology, the market is broadly segmented into immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis, and other technologies. The molecular diagnostics segment is estimated to register the highest CAGR during the forecast period of 2017 to 2022. The rising prevalence of infectious diseases, cancer, and various genetic disorders; growing demand for blood screening; and increasing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing is expected to drive the growth of the market during the forecast period.

Based on application, the market is segmented into diabetes, infectious diseases, oncology/cancer, cardiology, HIV/AIDS, autoimmune diseases, nephrology, drug testing/pharmacogenomics, and others. The infectious diseases segment accounted for the largest share of the market in 2016, owing to the rising incidence of tuberculosis (TB), hepatitis, and hospital-acquired infections.

Geographically, China dominated the IVD market in BRIC in 2016. The large share of this country can be attributed to rising healthcare expenditure, increasing acceptance of personalized medicine, and increasing awareness towards technologically advanced products in this country. China is also expected to register the highest CAGR, due to the growth in research activities and increasing investments by leading players and government agencies in the country.

Major players in the IVD market in BRIC and other emerging countries are Roche Diagnostics (Switzerland), Abbott Laboratories Inc. (U.S.), Siemens Healthineers (Germany), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Sysmex Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMerieux (France), Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), Ortho-Clinical Diagnostics, Inc. (U.S.), QIAGEN N.V. (Germany), and Diasorin S.P.A. (Italy).

Research Coverage:

  • Detailed insights on all the submarkets, based on technology (immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis, and other technologies), this can help market players to identify high growth segments in the IVD market in BRIC and other emerging countries
  • The report provides information on BRIC and other emerging countries such as Mexico, Turkey, Chile, Argentina, Colombia, South Korea, Indonesia, Malaysia, Thailand, and Saudi Arabia in this market. This can help the company to assess the competition across emerging countries in a better manner.
  • The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition across BRIC and other emerging countries in a better manner.
  • Key insights and market sizing for the different end users of the IVD market namely, hospital-based laboratories, clinical/reference laboratories, academic institutes, point-of-care testing, patient self-testing, and other end users.
  • BRIC and other emerging country-wise market size and forecast for all the subsegments. The market size numbers provided in the report will also enable market players to identify key geographic markets, and thereby strategize their marketing efforts to achieve sustainable revenue growth in the coming years.
  • It provides key insights on market dynamics, such as drivers, restraints, opportunities, and challenges for this market.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for increasing their market shares.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by top players in the IVD market. The report analyzes the market by product type across the BRIC and other emerging countries
  • Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the IVD market in BRIC and other emerging countries
  • Market Development: Comprehensive information on lucrative emerging markets, based on products & services, technology, application, end user, and country
  • Market Diversification: Exhaustive information about new products, growing countries, recent developments, and investments in the IVD market in BRIC and other emerging countries
  • Competitive Assessment: Growth strategies, products, distribution networks, and manufacturing capabilities of leading players in the IVD market in BRIC and other emerging countries

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. IVD MARKET IN EMERGING COUNTRIES: MARKET OVERVIEW
  • 4.2. IVD IN EMERGING COUNTRIES, BY PRODUCT & SERVICE

5. INDUSTRY INSIGHTS

  • 5.1. INTRODUCTION
  • 5.2. INDUSTRY TRENDS
    • 5.2.1. HIGH FOCUS OF IVD PLAYERS ON CHINA
    • 5.2.2. MICROFLUIDICS-BASED POC AND LOC DIAGNOSTIC DEVICES FOR LABORATORY TESTING
    • 5.2.3. RISE IN NUMBER OF REAGENT RENTAL AGREEMENTS
  • 5.3. REGULATORY OVERVIEW
    • 5.3.1. CHINA
    • 5.3.2. INDIA
    • 5.3.3. MALAYSIA
    • 5.3.4. THAILAND
    • 5.3.5. INDONESIA
    • 5.3.6. RUSSIA
    • 5.3.7. SAUDI ARABIA
    • 5.3.8. MEXICO
    • 5.3.9. SOUTH KOREA

6. MARKET OVERVIEW

  • 6.1. INTRODUCTION
  • 6.2. MARKET DYNAMICS
    • 6.2.1. MARKET DRIVERS
      • 6.2.1.1. Rising incidence of chronic lifestyle diseases
      • 6.2.1.2. Rapid growth in the geriatric population
      • 6.2.1.3. Increasing adoption of point-of-care testing
      • 6.2.1.4. Growing awareness of personalized medicine
      • 6.2.1.5. Growth in the number of private diagnostic centers
    • 6.2.2. MARKET RESTRAINTS
      • 6.2.2.1. Inadequate reimbursement
      • 6.2.2.2. Economic slowdown in Latin America
    • 6.2.3. MARKET OPPORTUNITIES
      • 6.2.3.1. Improving healthcare systems in emerging markets
      • 6.2.3.2. Growing significance of companion diagnostics
    • 6.2.4. MARKET CHALLENGES
      • 6.2.4.1. Stringent regulatory framework in Latin America
      • 6.2.4.2. Operational barriers to the use of diagnostic tests

7. IVD MARKET IN EMERGING COUNTRIES, BY PRODUCT & SERVICE

  • 7.1. INTRODUCTION
  • 7.2. REAGENTS & KITS
  • 7.3. INSTRUMENTS
  • 7.4. DATA MANAGEMENT SYSTEMS/SOFTWARE
  • 7.5. SERVICES

8. IVD MARKET IN EMERGING COUNTRIES, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. IMMUNOASSAY/IMMUNOCHEMISTRY
    • 8.2.1. ENZYME-LINKED IMMUNOSORBENT ASSAY
      • 8.2.1.1. Chemiluminescence immunoassays
      • 8.2.1.2. Fluorescence immunoassays
      • 8.2.1.3. Colorimetric immunoassays
    • 8.2.2. RADIOIMMUNOASSAY
    • 8.2.3. RAPID TESTS
    • 8.2.4. WESTERN BLOT
    • 8.2.5. ENZYME-LINKED IMMUNOSPOT ASSAY
  • 8.3. CLINICAL CHEMISTRY
    • 8.3.1. BASIC METABOLIC PANEL
    • 8.3.2. ELECTROLYTE PANEL
    • 8.3.3. LIVER PANEL
    • 8.3.4. LIPID PROFILE
    • 8.3.5. RENAL PROFILE
    • 8.3.6. THYROID FUNCTION PANEL
    • 8.3.7. SPECIALTY CHEMICAL TESTS
  • 8.4. MOLECULAR DIAGNOSTICS
    • 8.4.1. POLYMERASE CHAIN REACTION
    • 8.4.2. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY
    • 8.4.3. MICROARRAYS
    • 8.4.4. HYBRIDIZATION
    • 8.4.5. DNA SEQUENCING & NEXT-GENERATION SEQUENCING
    • 8.4.6. OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
  • 8.5. CLINICAL MICROBIOLOGY
  • 8.6. HEMATOLOGY
  • 8.7. COAGULATION AND HEMOSTASIS
  • 8.8. OTHER IVD TECHNOLOGIES

9. IVD MARKET IN EMERGING COUNTRIES, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. DIABETES
  • 9.3. INFECTIOUS DISEASES
  • 9.4. ONCOLOGY/CANCER
  • 9.5. CARDIOLOGY
  • 9.6. NEPHROLOGY
  • 9.7. AUTOIMMUNE DISEASES
  • 9.8. DRUG TESTING/PHARMACOGENOMICS
  • 9.9. HIV/AIDS
  • 9.10. OTHER APPLICATIONS

10. IVD MARKET IN EMERGING COUNTRIES, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. HOSPITAL-BASED LABORATORIES
  • 10.3. CLINICAL/REFERENCE LABORATORIES
  • 10.4. POINT-OF-CARE TESTING
  • 10.5. PATIENT SELF-TESTING
  • 10.6. ACADEMIC INSTITUTES
  • 10.7. OTHER END USERS

11. GEOGRAPHIC ANALYSIS: IVD MARKET IN EMERGING COUNTRIES

  • 11.1. INTRODUCTION
  • 11.2. CHINA
  • 11.3. INDIA
  • 11.4. RUSSIA
  • 11.5. BRAZIL
  • 11.6. MEXICO
  • 11.7. ARGENTINA
  • 11.8. COLOMBIA
  • 11.9. CHILE
  • 11.10. SOUTH KOREA
  • 11.11. TURKEY
  • 11.12. SAUDI ARABIA
  • 11.13. THAILAND
  • 11.14. MALAYSIA
  • 11.15. INDONESIA

12. COMPETITIVE LANDSCAPE

  • 12.1. INTRODUCTION
  • 12.2. VANGUARDS
  • 12.3. INNOVATORS
  • 12.4. EMERGING
  • 12.5. DYNAMIC
  • 12.6. COMPETITIVE BENCHMARKING

Top 13 companies analysed for this study are - Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Abbott Laboratories Inc. (U.S.), BioMerieux SA (France), Bio-Rad Laboratories Inc. (U.S.), Johnson and Johnson Inc.(U.S.), Sysmex Corporation (Japan), Becton, Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Diasorin S.P.A. (Italy), Qiagen N.V. (Germany), ERBA Diagnostics, Inc. (India), Mindray Medical International Limited (China), Hologic Inc. (U.S.), Illumina Inc. (U.S.), Werfen Life Group S.A. (Spain), A.Menarini Diagnostics Ltd. (U.K.), Quidel Corporation (U.S.), Span Divergent Ltd. (India), Trinity Biotech plc. (Republic of Ireland)

13. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 13.1. ROCHE DIAGNOSTICS
  • 13.2. ABBOTT LABORATORIES, INC.
  • 13.3. BECTON, DICKINSON AND COMPANY
  • 13.4. BIOMERIEUX SA
  • 13.5. BIO-RAD LABORATORIES, INC.
  • 13.6. DANAHER CORPORATION
  • 13.7. JOHNSON & JOHNSON SERVICES, INC.
  • 13.8. ORTHO-CLINICAL DIAGNOSTICS, INC.
  • 13.9. QIAGEN N.V.
  • 13.10. SYSMEX CORPORATION
  • 13.11. THERMO FISHER SCIENTIFIC INC.
  • 13.12. SIEMENS AG
  • 13.13. DIASORIN S.P.A.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5. AVAILABLE CUSTOMIZATIONS
  • 14.6. RELATED REPORTS
  • 14.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: IVD MARKET IN EMERGING COUNTRIES: MARKET SNAPSHOT (2017 VS. 2022)
  • TABLE 2: CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 3: INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 4: MALAYSIA: CLASSIFICATION OF IVD PRODUCTS
  • TABLE 5: THAILAND: REGISTRATION PROCESS FOR IVD DEVICES
  • TABLE 6: INDONESIA: REGISTRATION PROCESS FOR IVD DEVICES
  • TABLE 7: RUSSIA: CLASSIFICATION OF IVD DEVICES
  • TABLE 8: SAUDI ARABIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 9: MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 10: SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 11: NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2015 VS. 2040 (MILLION INDIVIDUALS)
  • TABLE 12: IMPACT ANALYSIS: MARKET DRIVERS
  • TABLE 13: IMPACT ANALYSIS: MARKET RESTRAINTS
  • TABLE 14: IMPACT ANALYSIS: MARKET OPPORTUNITIES
  • TABLE 15: IMPACT ANALYSIS: MARKET CHALLENGES
  • TABLE 16: IVD MARKET SIZE IN EMERGING COUNTRIES, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 17: IVD DATA MANAGEMENT SYSTEMS/SOFTWARE OFFERINGS BY KEY MARKET PLAYERS
  • TABLE 18: IVD REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: IVD INSTRUMENT OFFERINGS BY KEY MARKET PLAYERS
  • TABLE 20: IVD INSTRUMENTS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: IVD DATA MANAGEMENT SYSTEMS/SOFTWARE OFFERINGS BY KEY MARKET PLAYERS
  • TABLE 22: IVD DATA MANAGEMENT SYSTEMS/SOFTWARE MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: IVD SERVICE OFFERINGS BY KEY MARKET PLAYERS
  • TABLE 24: IVD SERVICES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: IVD MARKET SIZE IN EMERGING COUNTRIES, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 26: IVD MARKET SIZE FOR IMMUNOASSAY/IMMUNOCHEMISTRY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 27: ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 28: CHEMILUMINESCENCE IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: FLUORESCENCE IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: COLORIMETRIC IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 31: RADIOIMMUNOASSAY MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 32: RAPID TESTS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 33: WESTERN BLOT MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: ENZYME-LINKED IMMUNOSPOT ASSAY MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 35: IVD MARKET SIZE FOR CLINICAL CHEMISTRY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: IVD MARKET SIZE FOR CLINICAL CHEMISTRY, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 37: BASIC METABOLIC PANEL MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 38: ELECTROLYTE PANEL MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 39: LIVER PANEL MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 40: LIPID PROFILE MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 41: RENAL PROFILE MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: THYROID FUNCTION PANEL MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 43: SPECIALTY CHEMICAL TESTS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 44: IVD MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 45: IVD MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 46: POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 47: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 48: MICROARRAYS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 49: HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 50: DNA SEQUENCING & NGS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 51: OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 52: IVD MARKET SIZE FOR CLINICAL MICROBIOLOGY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 53: IVD MARKET SIZE FOR HEMATOLOGY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 54: IVD MARKET SIZE FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 55: OTHER IVD TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 56: IVD MARKET SIZE IN EMERGING COUNTRIES, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 57: DIABETIC PATIENT POPULATION, BY REGION, 2015 VS. 2040 (MILLION)
  • TABLE 58: IVD MARKET SIZE FOR DIABETES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 59: IVD MARKET SIZE FOR INFECTIOUS DISEASES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 60: IVD MARKET SIZE FOR ONCOLOGY/CANCER, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 61: IVD MARKET SIZE FOR CARDIOLOGY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 62: PREVALENCE OF PATIENTS ON DIALYSIS IN BRAZIL (2011 TO 2014)
  • TABLE 63: IVD MARKET SIZE FOR NEPHROLOGY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 64: IVD MARKET SIZE FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 65: IVD MARKET SIZE FOR DRUG TESTING/PHARMACOGENOMICS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 66: HIV PREVALENCE, BY REGION, 2010-2015
  • TABLE 67: IVD MARKET SIZE FOR HIV/AIDS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 68: IVD MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 69: IVD MARKET SIZE IN EMERGING COUNTRIES, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 70: IVD MARKET SIZE FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 71: IVD MARKET SIZE FOR CLINICAL/REFERENCE LABORATORIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 72: IVD MARKET SIZE FOR POC TESTING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 73: IVD MARKET SIZE FOR PATIENT SELF-TESTING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 74: IVD MARKET SIZE FOR ACADEMIC INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 75: IVD MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 76: IVD MARKET SIZE IN EMERGING COUNTRIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 77: CHINA: MACROECONOMIC INDICATORS
  • TABLE 78: CHINA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 79: CHINA: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 80: CHINA: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 81: CHINA: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 82: INDIA: MACROECONOMIC INDICATORS
  • TABLE 83: INDIA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 84: INDIA: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 85: INDIA: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 86: INDIA: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 87: RUSSIA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 88: RUSSIA: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 89: RUSSIA: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 90: RUSSIA: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 91: BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 92: BRAZIL: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 93: BRAZIL: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 94: BRAZIL: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 95: BRAZIL: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 96: MEXICO: MACROECONOMIC INDICATORS
  • TABLE 97: MEXICO: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 98: MEXICO: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 99: MEXICO: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 100: MEXICO: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 101: ARGENTINA: MACROECONOMIC INDICATORS
  • TABLE 102: ARGENTINA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 103: ARGENTINA: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 104: ARGENTINA: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 105: ARGENTINA: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 106: COLOMBIA: MACROECONOMIC INDICATORS
  • TABLE 107: COLOMBIA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 108: COLOMBIA: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 109: COLOMBIA: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 110: COLOMBIA: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 111: CHILE: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 112: CHILE: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 113: CHILE: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 114: CHILE: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 115: SOUTH KOREA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 116: SOUTH KOREA: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 117: SOUTH KOREA: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 118: SOUTH KOREA: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 119: TURKEY: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 120: TURKEY: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 121: TURKEY: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 122: TURKEY: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 123: SAUDI ARABIA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 124: SAUDI ARABIA: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 125: SAUDI ARABIA: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 126: SAUDI ARABIA: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 127: THAILAND: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 128: THAILAND: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 129: THAILAND: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 130: THAILAND: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 131: MALAYSIA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 132: MALAYSIA: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 133: MALAYSIA: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 134: MALAYSIA: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 135: INDONESIA: IVD MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 136: INDONESIA: IVD MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 137: INDONESIA: IVD MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 138: INDONESIA: IVD MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: IVD MARKET IN EMERGING COUNTRIES: MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: IVD MARKET SIZE IN EMERGING COUNTRIES, BY PRODUCT & SERVICE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 7: IVD MARKET SIZE IN EMERGING COUNTRIES, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 8: IVD MARKET SIZE IN EMERGING COUNTRIES, BY TECHNOLOGY, 2017 VS. 2022 (USD MILLION)
  • FIGURE 9: CLINICAL CHEMISTRY MARKET SIZE IN EMERGING COUNTRIES, BY TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: MOLECULAR DIAGNOSTICS MARKET SIZE IN EMERGING COUNTRIES, BY TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 11: IVD MARKET SIZE IN EMERGING COUNTRIES, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 12: IVD MARKET IN EMERGING COUNTRIES: GEOGRAPHIC SNAPSHOT
  • FIGURE 13: RISING INCIDENCE OF CHRONIC LIFESTYLE DISEASES IS A MAJOR DRIVER FOR THE GROWTH OF THE IVD MARKET IN EMERGING COUNTRIES
  • FIGURE 14: REAGENTS & KITS COMMANDED THE LARGEST MARKET SHARE IN 2016
  • FIGURE 15: REGULATORY PROCESS FOR IVD DEVICES IN INDIA
  • FIGURE 16: IVD MARKET IN EMERGING COUNTRIES: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: SHARE OF ELDERLY POPULATION IN LATIN AMERICA, BY COUNTRY, (2010 VS. 2015 VS. 2030)
  • FIGURE 18: GERIATRIC POPULATION STATISTICS, BY REGION (2015 VS. 2030 VS. 2050)
  • FIGURE 19: REAGENTS & KITS SEGMENT TO WITNESS THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 20: MOLECULAR DIAGNOSTICS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 21: ONCOLOGY IS THE FASTEST-GROWING APPLICATION SEGMENT IN THE IVD MARKET
  • FIGURE 22: CANCER INCIDENCE AND CANCER-RELATED DEATHS IN CHINA
  • FIGURE 23: IVD MARKET SIZE IN EMERGING COUNTRIES, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 24: NUMBER OF ACCREDITED CLINICAL LABORATORIES IN MEXICO (2005-2015)
  • FIGURE 25: CHINA: IVD MARKET OVERVIEW
  • FIGURE 26: INDIA: IVD MARKET OVERVIEW
  • FIGURE 27: RUSSIA: IVD MARKET OVERVIEW
  • FIGURE 28: BRAZIL: IVD MARKET OVERVIEW
  • FIGURE 29: DIVE CHART
  • FIGURE 30: PRODUCT OFFERINGS
  • FIGURE 31: BUSINESS STRATEGY
  • FIGURE 32: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2016)
  • FIGURE 33: ROCHE DIAGNOSTICS: PRODUCT OFFERINGS SCORECARD
  • FIGURE 34: ROCHE DIAGNOSTICS: BUSINESS STRATEGY SCORECARD
  • FIGURE 35: ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 36: ABBOTT LABORATORIES: PRODUCT OFFERINGS SCORECARD
  • FIGURE 37: ABBOTT LABORATORIES: BUSINESS STRATEGY SCORECARD
  • FIGURE 38: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 39: BECTON, DICKINSON AND COMPANY: PRODUCT OFFERINGS SCORECARD
  • FIGURE 40: BECTON, DICKINSON AND COMPANY: BUSINESS STRATEGY SCORECARD
  • FIGURE 41: BIOMERIEUX SA: COMPANY SNAPSHOT (2016)
  • FIGURE 42: BIOMERIEUX SA: PRODUCT OFFERINGS SCORECARD
  • FIGURE 43: BIOMERIEUX SA: BUSINESS STRATEGY SCORECARD
  • FIGURE 44: BIO-RAD LABORATORIES, INC. COMPANY SNAPSHOT (2016)
  • FIGURE 45: BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS SCORECARD
  • FIGURE 46: BIO-RAD LABORATORIES, INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 47: DANAHER CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 48: DANAHER CORPORATION: PRODUCT OFFERINGS SCORECARD
  • FIGURE 49: DANAHER CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 50: JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 51: JOHNSON & JOHNSON SERVICES, INC.: PRODUCT OFFERINGS SCORECARD
  • FIGURE 52: JOHNSON & JOHNSON SERVICES, INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 53: ORTHO-CLINICAL DIAGNOSTICS: PRODUCT OFFERINGS SCORECARD
  • FIGURE 54: ORTHO-CLINICAL DIAGNOSTICS: BUSINESS STRATEGY SCORECARD
  • FIGURE 55: QIAGEN N.V.: COMPANY SNAPSHOT (2015)
  • FIGURE 56: QIAGEN N.V.: PRODUCT OFFERINGS SCORECARD
  • FIGURE 57: QIAGEN N.V.: BUSINESS STRATEGY SCORECARD
  • FIGURE 58: SYSMEX CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 59: SYSMEX CORPORATION: PRODUCT OFFERINGS SCORECARD
  • FIGURE 60: SYSMEX CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 61: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 62: THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS SCORECARD
  • FIGURE 63: THERMO FISHER SCIENTIFIC INC: BUSINESS STRATEGY SCORECARD
  • FIGURE 64: SIEMENS AG: COMPANY SNAPSHOT (2016)
  • FIGURE 65: SIEMENS AG: PRODUCT OFFERINGS SCORECARD
  • FIGURE 66: SIEMENS AG: BUSINESS STRATEGY SCORECARD
  • FIGURE 67: DIASORIN S.P.A.: COMPANY SNAPSHOT (2015)
  • FIGURE 68: DIASORIN S.P.A.: PRODUCT OFFERINGS SCORECARD
  • FIGURE 69: DIASORIN S.P.A.: BUSINESS STRATEGY SCORECARD
Back to Top